Analysis of fungal bloodstream infection in intensive care units in the Meizhou region of China: species distribution and resistance and the risk factors for patient mortality
Open Access
- 14 August 2020
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 20 (1) , 1-8
Abstract
Background: Fungal bloodstream infections (FBI) among intensive care unit (ICU) patients are increasing. Our objective was to characterize the fungal pathogens that cause bloodstream infections and determine the epidemiology and risk factors for patient mortality among ICU patients in Meizhou, China. Methods: Eighty-one ICU patients with FBI during their stays were included in the study conducted from January 2008 to December 2017. Blood cultures were performed and the antimicrobial susceptibility profiles of the resulting isolates were determined. Logistic multiple regression and ROC curve analysis were used to assess the risk factors for mortality among the cases. Results: The prevalence of FBI in ICU patients was 0.38% (81/21,098) with a mortality rate of 36% (29/81). Ninety-eight strains of bloodstream-infecting fungi, mainly Candida spp., were identified from these patients. Candida albicans was most common (43%). Two strains of C. parapsilosis were no-sensitive to caspofungin, C. glabrata were less than 80% sensitive to azole drugs. Logistic multiple regression showed that age, serum albumin, APACHE II score, three or more underlying diseases, and length of stay in ICU were independent risk factors for mortality in FBI. ROC curve analysis showed that APACHE II scores > 19 and serum albumin ≤25 g/L were the best predictors of mortality. Conclusion: Candida spp. predominated with high mortality rates among cases of FBI in ICU. Thus, clinical staff should enhance overall patient monitoring and concurrently monitor fungal susceptibility to reduce mortality rates.Keywords
All Related Versions
Funding Information
- Shanghai Key Laboratory of Medical Fungal Molecular Biology Open Project Foundation (14DZ2272900)
This publication has 30 references indexed in Scilit:
- Nationwide Study of Candidemia, Antifungal Use, and Antifungal Drug Resistance in Iceland, 2000 to 2011Journal of Clinical Microbiology, 2013
- Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic optionsJournal of Medical Microbiology, 2013
- Aging Beijing: Challenges and strategies of health care for the elderlyAgeing Research Reviews, 2010
- Epidemiology of invasive candidiasisCurrent Opinion in Critical Care, 2010
- Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shockJournal of Critical Care, 2010
- Risk Factors for Fluconazole-Resistant Candida glabrata Bloodstream InfectionsArchives of internal medicine (1960), 2009
- Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitalsDiagnostic Microbiology and Infectious Disease, 2007
- Outbreak of fungemia due to Candida parapsilosis in a pediatric oncology unitDiagnostic Microbiology and Infectious Disease, 2004
- Attributable Mortality of Nosocomial Candidemia, RevisitedClinical Infectious Diseases, 2003
- International Surveillance of Bloodstream Infections Due to Candida Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance ProgramJournal of Clinical Microbiology, 2001